COVID-19: Impact of and on Diabetes

被引：0
作者：
Jonathan Schofield
Lalantha Leelarathna
Hood Thabit
机构：
[1] Manchester University Hospitals NHS Foundation Trust,Manchester Diabetes Centre
[2] University of Manchester,Faculty of Biology Medicine and Health
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
Coronavirus; COVID-19; Diabetes; Hyperglycaemia; Service development;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Diabetes has been identified as a pre-existing health condition linked with worse outcomes following coronavirus disease 2019 infection. Here we explore the association between hyperglycaemia and more severe illness, the impact of the pandemic on diabetes service delivery, and the resultant opportunities for innovation.
引用
收藏
页码：1429 / 1435
页数：6
相关论文
共 49 条
[11]  
Dong Y(2013)The effect of exogenous glucose-dependent insulinotropic polypeptide in combination with glucagon-like peptide-1 on glycemia in the critically ill Diabetes Care 37 723-177
[12]  
Hansen TK(2020)COVID-19 and diabetes Diabet Med 162 108132-310
[13]  
Huang C(2020)COVID-19, diabetes mellitus and ACE2: the conundrum Diabetes Res Clin Pract 495 251-172
[14]  
Hussain A(2013)Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC Nature 49 164-199
[15]  
Bhowmik B(2018)Virus-induced interferon-γ causes insulin resistance in skeletal muscle and derails glycemic control in obesity Immunity 14 303-95
[16]  
Moreira NCV(2020)Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations Diabetes Metab Syndr 11 59-1448
[17]  
Jafar N(2019)From SARS to MERS. Thrusting coronaviruses into the spotlight Viruses 131 165-740
[18]  
Edriss H(2018)Infection and malignancy outweigh cardiovascular mortality in kidney transplant recipients: post hoc analysis of the FAVORIT trial Am J Med 47 193-undefined
[19]  
Nugent K(2010)Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes Acta Diabetol 94 91-undefined
[20]  
Leelarathna L(2020)Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis Int J Infect Dis. 367 1444-undefined
12345